In our previous study, DHM supplementation promoted lipid metabolism in NAFLD patients [23], attenuated hepatic steatosis and maintained redox homeostasis through increased SIRT3 expression [24]. This evidence concerns the gene SIRT3 and metabolic dysfunction-associated steatotic liver disease.